⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT August 18, 2026

Alluzience 200 Speywood-Einheiten/ml Injektionslösung 200 U/ml (Injektionslösung)

📷 EU Safety Watch placeholder
Alluzience 200 Speywood-Einheiten/ml Injektionslösung 200 U/ml (Injektionslösung)
📷 EU Safety Watch placeholder
Alluzience 200 Speywood units/ml injection solution 200 U/ml (injection solution) Reason: Increased additional demand Marketing authorisation holder: Ipsen Pharma, 70 Rue Balard, 75015 Paris, French Republic Affected packs: 2-piece box, vial Not available since 2026-08-06, resupply 2026-08-31
✅
Resolved by agency
The issuing agency has confirmed this medicine alert is over — the underlying issue was addressed. Originally reported 23 days ago.
📈 Timeline
6 days in total
August 20, 2026 August 26, 2026

What is this? Alluzience is a medicine given as an injection. It contains a small amount of a protein from bacteria to help with muscle problems.

What's happening? The medicine is not available right now. It will be back in stock on August 31.

Does this affect me? If you use Alluzience, you may not be able to get it until the end of August.

What should I do? Ask your doctor or pharmacist for advice before your next dose.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Agency-published detail

ATC: M03AX01 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: Ipsen Pharma, 70 Rue Balard -, 75015 Paris, French Republic · Affected packs: 2 Stück Schachtel, Durchstechflasche [Nicht verfügbar, since 2026-08-06, resupply 2026-08-31]

First published
August 18, 2026
Last refreshed by us
2 weeks ago
Severity (as classified)
Low
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

Medium AT 2 weeks ago

Bexsero Injektionssuspension in Fertigspritze Impfstoff gegen Meningokokken der Gruppe B (rDNA, Komponenten, adsorbiert) (Injektionssuspension)

Bexsero injection suspension in pre-filled syringe is a vaccine against meningococcal group B disease (rDNA, component, adsorbed) (injection suspension). Parallel export is banned due to limited prod...
Medium AT resolved 2 months ago

Boostrix Injektionssuspension in einer Fertigspritze (Injektionssuspension in einer Fertigspritze)

Parallel export ban in effect.
Medium AT resolved 4 months ago

Trumenba Injektionssuspension in einer Fertigspritze, Meningokokken-Gruppe B-Impfstoff (rekombinant, adsorbiert) (Injektionssuspension)

Trumenba injection suspension in a pre-filled syringe, meningococcal group B vaccine (recombinant, adsorbed) (injection suspension)
Medium AT resolved 10 months ago

Shingrix Pulver und Suspension zur Herstellung einer Injektionssuspension, Herpes-Zoster-Impfstoff (rekombinant, adjuvantiert) (Pulver und Suspension zur Herstellung einer Injektionssuspension)

Shingrix powder and suspension for preparing an injectable suspension, herpes zoster vaccine (recombinant, adjuvanted) (powder and suspension for preparing an injectable suspension) Parallel export i...

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Alluzience 200 Speywood-Einheiten/ml Injektionslösung 200 U/ml (Injektionslösung). Alluzience 200 Speywood units/ml injection solution 200 U/ml (injection solution) Reason: Increased additional demand Marketing authorisation holder: Ipsen Pharma, 70 Rue Balard, 75015 Paris, French Republic Affected packs: 2-piece box, vial Not available since 2026-08-06, resup...
▸ When was this alert issued?
This alert was issued on August 18, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Low risk. A low risk means harm is unlikely under normal use. The alert is informational but still worth reading.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.